The coagulation system has gained much interest again as new anticoagulatory substances
have been introduced into clinical practice. Especially patients with renal failure are likely …

More than half of all deaths among end stage renal disease (ESRD) patients are due to
cardiovascular disease (CVD). Cardiovascular changes secondary to renal dysfunction …

Patients with end-stage renal disease suffer from complex hemostatic disorders. Uremic
patients show a bleeding diathesis that is mainly due to abnormalities of primary …

Patients with end‐stage renal disease (ESRD) develop hemostatic disorders mainly in the
form of bleeding diatheses. Hemorrhage can occur at cutaneous, mucosal, or serosal sites …

Neurological complications whether due to the uremic state or its treatment, contribute
largely to the morbidity and mortality in patients with renal failure. Despite continuous …

Baboons that were subjected to systemic hypothermia at 32 C had an arm skin temperature
of 27.3 C and bleeding time of 5.8 minutes. With local warming of the arm skin to 34 C, the …

Hospitalised patients with decompensated cirrhosis are in a rebalanced haemostatic state
due to a parallel decline in both pro-and anti-haemostatic pathways. However, this …

Uremic bleeding syndrome is a recognized consequence of renal failure and can result in
clinically significant sequelae. Although the pathophysiology of the condition has yet to be …

Normal hemostasis is initiated by damage of the vessel wall with exposure of subendothelial
structures to flowing blood and results in the formation of a solid hemostatic plug. The first …

Patients with CKD display a significantly higher risk of cardiovascular and thromboembolic
complications, with around half of patients with advanced CKD ultimately dying of …